Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study

Galit Weinstein1, Alexa S Beiser, Charles Decarli

  • 1From the Department of Neurology, Boston University School of Medicine, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); The Framingham Heart Study, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (A.S.B.); and the Department of Neurology, University of California at Davis, Sacramento, CA (C.D.).

Stroke
|August 8, 2013
PubMed
Abstract

Related Concept Videos

Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...